GEOapplication/xmlftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE316nnn/GSE316902/primary200OKTranscriptomicsCandidozyma auris Candida albicansExpression profiling by high throughput sequencinghttps://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316902GEOGSEfalseEffect of NFAP2 treatment on early-stage filamentous Candida albicans and pseudohyphal Candida auris culturesThe Neosartorya (Aspergillus) fischeri antifungal protein 2 (NFAP2) represents a particularly promising candidate in the fight against fungal infections. To facilitate the progression of NFAP2 toward clinical application, a comprehensive understanding of its antifungal mode of action against filamentous Candida forms is essential. In the present study, we analyzed the transcriptomic responses of filamentous Candida albicans and pseudohyphal Candidozyma (Candida) auris cells following exposure to NFAP2.2026/06/26GSE316902GSM9462220GSM9462199GSM9462210GSM9462200GSM9462211GSM9462201GSM9462212GSM9462213GSM9462202GSM9462203GSM9462214GSM9462215GSM9462204GSM9462216GSM9462205GSM9462206GSM9462217GSM9462218GSM9462207GSM9462219GSM9462208GSM94622093521835766316902Candidozyma auris Candida albicans